John Abraham – författare
Visar alla böcker från författaren John Abraham. Handla med fri frakt och snabb leverans.
24 produkter
24 produkter
Inbunden, Engelska, 2020
1 774 kr
Skickas inom 10-15 vardagar
This book elaborately covers all topics of swine management like breeding, feeding, housing, health management and pork production technology.The book is well supported by a large number of illustrations and tables which makes the understanding of the text very simple and easy. It will be very useful for all students as well as professionals.Note: T& F does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka.
Häftad, Engelska, 2000
517 kr
Skickas inom 10-15 vardagar
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations,it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance.
E-bok
PDF, Engelska, 2020970 kr
Läs direkt efter köp
This book elaborately covers all topics of swine management like breeding, feeding, housing, health management and pork production technology.The book is well supported by a large number of illustrations and tables which makes the understanding of the text very simple and easy. It will be very useful for all students as well as professionals.Note: T& F does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka.
E-bok
Engelska, 2020970 kr
Läs direkt efter köp
This book elaborately covers all topics of swine management like breeding, feeding, housing, health management and pork production technology.The book is well supported by a large number of illustrations and tables which makes the understanding of the text very simple and easy. It will be very useful for all students as well as professionals.Note: T& F does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka.
E-bok
PDF, Engelska, 2023901 kr
Läs direkt efter köp
Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.; A highly original combination of philosophical rigour, historical sensitivity and empirical depth enables the "black box" of industrial and government science to be opened up to critical scrutiny much more than in previous social scientific study. All major aspects of drug testing and regulation are considered, including pre- clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions. The author argues that drug regulators are too dependent on pharmaceutical industry resources and expertise, and too divorced from public accountability. The problem of corporate bias is particularly severe in the UK, where regulatory decisions about medicine safety are shrouded in greater secrecy than in the US.; Since the purpose of drug regulation should be to maximize the safety and effectiveness of medicines for patients, the public needs and deserves policies to counteract corporate bias in drug testing and evaluation. John Abraham''s realist analysis provides a robust basis for policy interventions at the institutional and legislative levels. He proposes that corporate bias could be reduced by more extensive freedom of information, greater autonomy of government scientists from pharmaceutical industry, the development of independent drug testing by the regulatory authority, increased patient representation on regulatory committees, and more frequent and thorough oversight of regulatory performance by the legislature. This book should be of interest to anyone who cares about how medicines should be controlled in modern society. It should prove particularly rewarding for students and researchers in the sociology of science and technology, science and medicines policy, medical sociologists, the medical and pharmaceutical professions, and consumer organizations.
E-bok
Engelska, 2023901 kr
Läs direkt efter köp
Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.; A highly original combination of philosophical rigour, historical sensitivity and empirical depth enables the "black box" of industrial and government science to be opened up to critical scrutiny much more than in previous social scientific study. All major aspects of drug testing and regulation are considered, including pre- clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions. The author argues that drug regulators are too dependent on pharmaceutical industry resources and expertise, and too divorced from public accountability. The problem of corporate bias is particularly severe in the UK, where regulatory decisions about medicine safety are shrouded in greater secrecy than in the US.; Since the purpose of drug regulation should be to maximize the safety and effectiveness of medicines for patients, the public needs and deserves policies to counteract corporate bias in drug testing and evaluation. John Abraham''s realist analysis provides a robust basis for policy interventions at the institutional and legislative levels. He proposes that corporate bias could be reduced by more extensive freedom of information, greater autonomy of government scientists from pharmaceutical industry, the development of independent drug testing by the regulatory authority, increased patient representation on regulatory committees, and more frequent and thorough oversight of regulatory performance by the legislature. This book should be of interest to anyone who cares about how medicines should be controlled in modern society. It should prove particularly rewarding for students and researchers in the sociology of science and technology, science and medicines policy, medical sociologists, the medical and pharmaceutical professions, and consumer organizations.
E-bok
PDF, Engelska, 2014402 kr
Läs direkt efter köp
How do drugs get to the market? What controls are there and what procedures for monitoring their effects? And how adequate are the regulators in protecting public health when new drugs have serious side effects? The Therapeutic Nightmare tells the story of the sleeping pill Halcion - a story which is far from over. First marketed in the 1970s, Halcion has been taken by millions of patients around the world. For many years it has been associated with serious adverse effects such as amnesia, hallucinations, aggression and, in extreme cases, homicide. Thirteen years after its first release, it was banned by the British government. It remains on sale in the United States and many other countries. This book explains why patients have come to be exposed to Halcion''s risks and examines the corporate interests of the manufacturers, the professional interests of the scientists and medical researchers and the interests of patients in safe and effective medication. It reveals how these contending forces shape the regulatory decision-making process about drug safety. As the number of new drugs and health products grows, a major challenge facing regulators and the medical profession is how to put the interests of public health decisively and consistently above the commercial interests of the drugs industry, while becoming more accountable to patient and consumer organizations.
E-bok
Engelska, 2014402 kr
Läs direkt efter köp
How do drugs get to the market? What controls are there and what procedures for monitoring their effects? And how adequate are the regulators in protecting public health when new drugs have serious side effects? The Therapeutic Nightmare tells the story of the sleeping pill Halcion - a story which is far from over. First marketed in the 1970s, Halcion has been taken by millions of patients around the world. For many years it has been associated with serious adverse effects such as amnesia, hallucinations, aggression and, in extreme cases, homicide. Thirteen years after its first release, it was banned by the British government. It remains on sale in the United States and many other countries. This book explains why patients have come to be exposed to Halcion''s risks and examines the corporate interests of the manufacturers, the professional interests of the scientists and medical researchers and the interests of patients in safe and effective medication. It reveals how these contending forces shape the regulatory decision-making process about drug safety. As the number of new drugs and health products grows, a major challenge facing regulators and the medical profession is how to put the interests of public health decisively and consistently above the commercial interests of the drugs industry, while becoming more accountable to patient and consumer organizations.
E-bok
PDF, Engelska, 2014606 kr
Läs direkt efter köp
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations,it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance.
E-bok
Engelska, 2014606 kr
Läs direkt efter köp
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations,it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance.
E-bok
Engelska, 2014572 kr
Läs direkt efter köp
First published in 1995. This book is concerned with how comprehensive schooling can act as a social system of class and gender differentiation. Based on a critical synthesis of feminist and sociological literature on secondary education, Abraham develops a theoretical and methodological framework for ethnographic research into the central gender and class dynamic of a comprehensive school.
E-bok
PDF, Engelska, 2014572 kr
Läs direkt efter köp
First published in 1995. This book is concerned with how comprehensive schooling can act as a social system of class and gender differentiation. Based on a critical synthesis of feminist and sociological literature on secondary education, Abraham develops a theoretical and methodological framework for ethnographic research into the central gender and class dynamic of a comprehensive school.
E-bok
Engelska, 201252 kr
Läs direkt efter köp
Living in THE SUPERNATURAL DIMENSION
A captivating and mind-stretching journey!
Living in the Supernatural Dimension takes you on a journey with God. You will learn about his voice alerts, His Global Positioning System, and His forks in the road. He will take the willing traveler to His highest and richest plateau.
YOU will be moved from where you are to where He would like you to be, as you listen and let God speak to you.YOU will learn about powerGods power in youto change you and your world.YOU will have a front row seat as Gods mind-stretching supernatural power is released to you and through you to a hurting world.YOU may experience anger, joy, fear, love, laughter, or tears.YOU are on a journey to an enriched life, bringing greater perspective and balance with sharper focus in Gods dimension of the supernatural.Follow the child preacher, now affectionately known around the world as the pastors pastor, from Russia to Africa, from Eastern Europe to Asia, who heard Gods call andsixty years of global ministry latertells it like it is. He tells what God alone has done in revolutionizing multitudes of lives, lives of people who now live in his victory.
Fact can be stranger than fiction, stretching many and too much for some.
Inbunden, Engelska, 1999
1 557 kr
Skickas inom 10-15 vardagar
How do drugs get to the market? What controls are there and what procedures for monitoring their effects? And how adequate are the regulators in protecting public health when new drugs have serious side effects? The Therapeutic Nightmare tells the story of the sleeping pill Halcion - a story which is far from over. First marketed in the 1970s, Halcion has been taken by millions of patients around the world. For many years it has been associated with serious adverse effects such as amnesia, hallucinations, aggression and, in extreme cases, homicide. Thirteen years after its first release, it was banned by the British government. It remains on sale in the United States and many other countries. This book explains why patients have come to be exposed to Halcion's risks and examines the corporate interests of the manufacturers, the professional interests of the scientists and medical researchers and the interests of patients in safe and effective medication. It reveals how these contending forces shape the regulatory decision-making process about drug safety. As the number of new drugs and health products grows, a major challenge facing regulators and the medical profession is how to put the interests of public health decisively and consistently above the commercial interests of the drugs industry, while becoming more accountable to patient and consumer organizations.
Häftad, Engelska, 2009
383 kr
Skickas inom 10-15 vardagar
How do drugs get to the market? What controls are there and what procedures for monitoring their effects? And how adequate are the regulators in protecting public health when new drugs have serious side effects? The Therapeutic Nightmare tells the story of the sleeping pill Halcion - a story which is far from over. First marketed in the 1970s, Halcion has been taken by millions of patients around the world. For many years it has been associated with serious adverse effects such as amnesia, hallucinations, aggression and, in extreme cases, homicide. Thirteen years after its first release, it was banned by the British government. It remains on sale in the United States and many other countries. This book explains why patients have come to be exposed to Halcion's risks and examines the corporate interests of the manufacturers, the professional interests of the scientists and medical researchers and the interests of patients in safe and effective medication. It reveals how these contending forces shape the regulatory decision-making process about drug safety. As the number of new drugs and health products grows, a major challenge facing regulators and the medical profession is how to put the interests of public health decisively and consistently above the commercial interests of the drugs industry, while becoming more accountable to patient and consumer organizations.
Häftad, Engelska, 1995
759 kr
Skickas inom 10-15 vardagar
Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in order to probe deeply into the work of scientists in the pharmaceutical industry and governmental drug regulatory authorities on both sides of the Atlantic. Through the examination of contemporary controversial case studies, he exposes how the commercial interest of drug manufacturers are consistently given the benefit of the scientific doubts about medicine safety and effectiveness, over and above the best interests of patients.; A highly original combination of philosophical rigour, historical sensitivity and empirical depth enables the "black box" of industrial and government science to be opened up to critical scrutiny much more than in previous social scientific study. All major aspects of drug testing and regulation are considered, including pre- clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions. The author argues that drug regulators are too dependent on pharmaceutical industry resources and expertise, and too divorced from public accountability. The problem of corporate bias is particularly severe in the UK, where regulatory decisions about medicine safety are shrouded in greater secrecy than in the US.; Since the purpose of drug regulation should be to maximize the safety and effectiveness of medicines for patients, the public needs and deserves policies to counteract corporate bias in drug testing and evaluation. John Abraham's realist analysis provides a robust basis for policy interventions at the institutional and legislative levels. He proposes that corporate bias could be reduced by more extensive freedom of information, greater autonomy of government scientists from pharmaceutical industry, the development of independent drug testing by the regulatory authority, increased patient representation on regulatory committees, and more frequent and thorough oversight of regulatory performance by the legislature. This book should be of interest to anyone who cares about how medicines should be controlled in modern society. It should prove particularly rewarding for students and researchers in the sociology of science and technology, science and medicines policy, medical sociologists, the medical and pharmaceutical professions, and consumer organizations.
Häftad, Engelska, 2021
165 kr
Skickas inom 5-8 vardagar
66 kr
Läs direkt efter köp
E-bok
Engelska116 kr
Läs direkt efter köp
In the golden light of Ottoman Gaza, Muslim, Jewish, and Christian neighbors lived side by side in harmony. Young Fatima and Ishmael walked the bustling bazaar together, surrounded by the scent of fresh bread, olive oil, and jasmine. Justice flowed naturally from the teachings of the Qur'an, and peace felt as enduring as the ancient olive trees.Generations later, their descendant Mariam lives in a very different Gaza. Under occupation, the same streets carry tension and fear. Olive groves that once symbolized abundance now stand under constant threat. As she teaches the children and defends the land, Mariam embarks on a deeper journey — a return to the Qur'an not merely as recitation, but as a living guide for conscience, courage, and moral clarity."e;The Olive Trees Remember"e; is a sweeping multi-generational novel that moves between the peaceful coexistence of the past and the painful struggles of the present. Through the enduring symbolism of the olive trees — silent witnesses to history, suffering, and resilience — the story explores the slow erosion of justice and the quiet power of spiritual awakening.A profound meditation on faith, memory, and the human spirit, this novel asks what it means to reclaim dignity and meaning when the world around you has been transformed by conflict and loss.
Del 1 - Olive
Olive Trees Remember
Häftad, Engelska, 2026
266 kr
Skickas inom 5-8 vardagar
Del 2 - Olive
Bread is Still Warm
Häftad, Engelska, 2026
251 kr
Skickas inom 5-8 vardagar
E-bok
Engelska, 2026124 kr
Läs direkt efter köp
In Gaza, survival is measured not in years, but in breaths, in moments between explosions, in the warmth of bread passed from hand to hand.The Bread Is Still Warm follows Mariam as she navigates streets reshaped by destruction, where childhood is a skill, memory is resistance, and every act of care—sharing food, lighting a candle, whispering a name—is defiance against erasure. Here, children lead where adults cannot, families endure when hope seems lost, and the city itself becomes a living testament to human perseverance.Through quiet acts of solidarity, whispered prayers, and the persistent rhythm of daily life, Gaza emerges not only as a place of loss but as a stage for resilience. From shattered playgrounds to makeshift shelters, from shared tea to stories of survival, Mariam witnesses how dignity, memory, and humanity refuse to be extinguished.The Bread Is Still Warm is a story of endurance, witness, and moral courage—of ordinary lives carrying the weight of extraordinary violence, and of the small gestures that keep the soul alive.
Inbunden, Engelska, 1999
1 065 kr
Tillfälligt slut
Häftad, Engelska, 2020
145 kr
Tillfälligt slut